ReportWire

Tag: organ transplants

  • To find living donors for kidney transplants, a pilot program turns to social networks

    HARRISBURG, Pa. — Fernando Moreno has been on dialysis for about two years, enduring an “unbearable” wait for a new kidney to save his life. His limited world of social contacts has meant that his hopes have hinged on inching up the national waiting list for a transplant.

    That was until earlier this year, when the Philadelphia hospital where he receives treatment connected him with a promising pilot project that has paired him with “angel advocates” — Good Samaritan strangers scattered around the country who leverage their own social media contacts to share his story.

    So far, the Great Social Experiment, as it was named by its founder, Los Angeles filmmaker David Krissman, hasn’t found the Vineland, New Jersey, truck driver a living kidney donor. But there are encouraging early signs the angel advocate approach is working, and there’s no question it has given Moreno new optimism.

    “This process is great,” said Moreno, 50, whose own father died of kidney failure at 65. “I’m just hoping there will be somebody out there that’s willing to take a chance.”

    Moreno is part of a pilot program with 15 patients that began in May at three Pennsylvania hospitals. It’s testing whether motivated, volunteer strangers can help improve the chances of finding a life-saving match for a new kidney — particularly for people with limited social networks.

    “We know how this has always been done, and we’re trying to put that on steroids and really get them the help that they need,” Krissman said. “Most patients are too sick to do this on their own — many don’t have the skills to do it on their own.”

    The Gift of Life Donor Program, which serves as the organ procurement network for eastern Pennsylvania, southern New Jersey and Delaware, is supporting the pilot program with a grant of more than $100,000 from its foundation.

    So far, two of the five patients in the program through Temple University Hospital have found kidney donors, and one is preparing for surgery, according to Ryan Ihlenfeldt, the hospital’s director of clinical transplant services. One of the five patients at the University of Pittsburgh Medical Center in Harrisburg has also undergone a transplant.

    The approach Krissman has developed is something new, said Richard Hasz Jr., Gift of Life’s chief executive, and may help identify the types of messages that attract and motivate potential live kidney donors.

    “This is the first of its kind that I’m aware of,” Hasz said. “That’s why, I think, the foundation was so interested in doing it — studying it and hopefully publishing it — so we can create that blueprint, if you will, for the future.”

    Gift of Life agreed to fund a broader test and helped Krissman identify five patients each at Temple, UPMC-Harrisburg and Jefferson University Hospital in Philadelphia.

    Hasz said the pilot program’s approach combines social media outreach with Krissman’s storytelling talents and aggressive efforts to mobilize the patients’ own connections.

    “We know that patients who are waiting don’t always have the energy or the resources to do this themselves,” Hasz said.

    There have been other ways for patients to set up “ microsites ” where they can tell their stories and seek a donor match. But the pilot program currently underway in Pennsylvania aims to connect patients with a wide universe of potential donors and produce videos and other ways to spread their message.

    Krissman’s bout with an illness about two decades ago inspired him to tackle the sticky challenge of increasing live kidney donations. He was debilitated for more than a year before medication helped him recover, explaining, “It gave me my life back. And I never forgot what it’s like to be chronically sick.”

    After producing a podcast on kidney transplantation, Krissman recruited four patients through Facebook who were waiting for kidneys. He was able to help two of them. A second effort, a pilot program with three patients in North Carolina that ended last year, helped match all three with living donors.

    Becca Brown, director of transplant services at UPMC-Harrisburg, thinks it might be a game changer.

    “There’s potential for this to really snowball,” Brown said. “I’m anxious to see what happens and if we can roll it out to other patients.”

    Some 90,000 people in the United States are on a list for a kidney transplant, and most of the roughly 28,000 kidneys that were transplanted last year came from deceased donors. Living kidney donations are hard to come by — about 6,400 were transplanted last year. Thousands die each year waiting for an organ transplant in the United States.

    Living kidney donations can be a better match, reducing the risk of organ rejection. They allow for surgery to be planned for a time that is optimal for the donor, the recipient and the transplant team. And, the foundation says, living donor kidneys, on average, last longer than kidneys from deceased donors.

    The National Kidney Foundation says living donors must be at least 18 years old, although some transplant centers set the minimum age at 21. Potential donors get screened for health problems and can be ruled out if they have uncontrolled high blood pressure, diabetes or cancer, or if they are smokers.

    Many living donors make “directed donations” to specify who will get their kidney. Nondirected donations are made anonymously to a patient.

    Francis Beaumier, a 38-year-old information technology worker from Green Bay, Wisconsin, came into contact with the angel advocate program after being a double living donor — a kidney and part of his liver.

    He sees the program as “a great little way for everyone to make a small difference.”

    Another angel advocate, Holly Armstrong, was also a living donor. She hopes her efforts will plant a seed.

    “Some people might just keep scrolling,” said Armstrong, who lives in Lake Wiley, South Carolina. “But there might be someone like me, where they stop scrolling and say, ‘This boy needs a kidney.’”

    A study released last year found that people who volunteer to donate a kidney are at a lower risk of death from the operation than doctors had previously thought. Tracking 30 years of living kidney donations, researchers found fewer than 1 in every 10,000 donors died within three months of the surgery. Newer and safer surgical techniques were credited for dropping the risk from 3 deaths per 10,000 living donors.

    Temple serves a large cohort of poorer patients who can have difficulty understanding health issues and who suffer from uncontrolled hypertension and diabetes, Ihlenfeldt, who works there, said.

    “What David’s trying to do is coalesce a network of support around these patients who are sharing the story for them,” Ihlenfeldt said.

    At a kickoff event in a Harrisburg meeting room for kidney patient Ahmad Collins, a couple dozen friends and family listened with rapt attention as Krissman went over the game plan, answering questions and describing the transplant process.

    Collins, a 50-year-old city government worker and former Penn State linebacker, has needed 10 hours a night of dialysis since a medical procedure left him with damaged kidneys late last year.

    His mind was on the strangers who might decide to pitch in.

    “They can be a superhero, so to speak,” Collins said. “They can have the opportunity to save somebody’s life, and not too many times in life do you have that opportunity.”

    Source link

  • Ex-Browns QB Bernie Kosar has liver transplant after over a year on the waiting list

    CLEVELAND — Bernie Kosar received a liver transplant on Monday, more than a year after being placed on the waiting list.

    “Hey, I’m out and I’m feeling good. Just ready to enjoy the rest of the week and the rest of our lives,” the former Cleveland Browns and University of Miami quarterback said in a brief video posted on social media following the surgery.

    Kosar told Cleveland Magazine last year that he had been diagnosed with cirrhosis of the liver and Parkinson’s disease.

    The 61-year-old from Youngstown recalled being bothered by liver-related issues for years but brushed them off because he wasn’t sure of the source. A diagnosis of cirrhosis in late 2023 confirmed the specificity and severity of his condition.

    He went on the transplant waiting list last July. He was scheduled to receive a liver transplant last weekend but said that it was delayed because the donor’s organ was infected.

    During the past week, he has undergone five procedures to stop internal bleeding.

    Kosar played in the NFL for 12 seasons after leading Miami to its first national championship during the 1983 season. He grew up rooting for the Browns, who selected him in the 1985 NFL supplemental draft.

    Kosar played for the Browns from 1985-93, leading the franchise to three AFC championship game appearances (1986, ’87 and ’89), losing each time to the Denver Broncos. Kosar is third all time in franchise history with 21,904 passing yards.

    After being released by the Browns, Kosar joined the Dallas Cowboys for the remainder of the 1993 season and got a Super Bowl ring. He then played for the Miami Dolphins in 1994-96.

    The Browns played a tribute video for Kosar before Sunday’ game against the Baltimore Ravens. Coach Kevin Stefanski said Monday that he texted with Kosar on Sunday night and wished him luck.

    “Yeah, I mean, Bernie’s my guy. I know that this town has such a special relationship with Bernie from his playing days and then the impact that he’s had on this community over the course of all these years,” Stefanski said. “I didn’t have that experience with Bernie prior to coming here, but since I’ve been here, he has just been such a supportive person of me, so kind to my family. I think he sees my family every game day and just is so good to them. So, he’s a special person. He’s a special Cleveland Brown, and we are all rooting for him and we are all right there with him right now.”

    ___

    AP NFL: https://apnews.com/hub/NFL

    Source link

  • Man Has Pig Kidney Removed After Living With It for a Record 9 Months

    Surgeons at Massachusetts General Hospital have removed a genetically engineered pig kidney from a 67-year-old New Hampshire man after a period of decreasing kidney function, the hospital confirmed to WIRED in a statement. The organ functioned for nearly nine months, longer than previous pig organ transplants, before it was removed on October 23.

    Tim Andrews received the pig kidney on January 25 after being on dialysis for more than two years due to end-stage kidney disease. His rare blood type meant that he faced a much longer wait time for a human donor kidney than most patients, who already wait on average three to five years for a kidney.

    The shortage of human donors has pushed scientists to look to animals as a potential source of organs. Kidneys are the most in demand, with nearly 90,000 people waiting to receive one in the US alone. Due to the shortage of organs, the US performed just 28,000 kidney transplants in 2024.

    Pig organs are being explored as an option, though genetic differences between pigs and humans mean they would be swiftly rejected if they were transplanted into a person. Scientists have therefore turned to gene editing to make pig organs more compatible with the human body, and have so far carried out a handful of experimental transplants.

    Andrews was the fourth person in the world to receive a kidney from a genetically engineered donor pig. The first, Richard Slayman, whose surgery was also performed at Massachusetts General, died in May 2024 almost two months after his transplant. A second person, Lisa Pisano, had a combined pig kidney transplant and heart pump surgery at NYU Langone Health, but had the kidney removed in May 2024 after less than two months due to failure. Pisano later passed away. Towana Looney became the third pig kidney recipient, again at NYU Langone, and lived with the organ for more than four months before surgeons removed it in April this year due to organ rejection.

    Since Andrews’ surgery, a patient in China has received an edited pig kidney, and surgeons at Massachusetts General have transplanted one into another patient, 54-year-old Bill Stewart, bringing the total number of people known to have received pig kidneys to six.

    Before the pig kidney transplants, two patients received genetically engineered pig hearts at the University of Maryland in 2022 and 2023 but never became healthy enough to leave the hospital. They both died within two months of their procedures.

    Emily Mullin

    Source link

  • New Hampshire man resumes dialysis after record 271 days living with a pig kidney

    WASHINGTON — A New Hampshire man is resuming dialysis after living with a gene-edited pig kidney for a record 271 days, doctors said Monday. His experience is helping researchers in their quest for animal-to-human transplants.

    Tim Andrews, 67, had the organ removed on Oct. 23 because its function was declining, according to Mass General Brigham. In a statement, his transplant team called Andrews “a selfless medical pioneer and an inspiration” to patients with kidney failure.

    Andrews’ experience illustrates lessons researchers have learned with each experiment involving what’s called xenotransplantation. The first attempts using pig organs gene-edited to be more humanlike – two hearts and two kidneys – were short-lived.

    Then researchers began considering patients not nearly as sick as prior recipients for these experiments — and an Alabama woman’s pig kidney lasted 130 days before it had to be removed last spring, the record Andrews surpassed.

    More than 100,000 people, most needing kidneys, are on the U.S. transplant list, and thousands die waiting.

    Andrews, of Concord, New Hampshire, knew his blood type is particularly hard to match and sought an alternative, getting into shape to qualify for Mass General’s xenotransplant pilot study. His doctors said he remains on the transplant list.

    In June, the Mass General team transplanted a pig kidney into another New Hampshire man who continues to fare well. The pilot study is set to conclude with a third pig kidney transplant later this year.

    Two companies, eGenesis and United Therapeutics, are preparing to begin more rigorous clinical trials of pig kidney transplants.

    Surgeons in China also are pursuing this new field, reporting a pig kidney transplant last spring and separately a transplanted pig liver that had to be removed after 38 days.

    ___

    The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

    Source link

  • Trump administration to close Miami organ donation group it calls ‘failing’

    WASHINGTON — The Trump administration moved Thursday to shut down a Miami organ donation group, calling it “failing” because of underperformance, unsafe practices and paperwork errors.

    The Life Alliance Organ Recovery Agency is one of 55 organ procurement organizations, or OPOs, nonprofit agencies around the country that coordinate the recovery of organs from deceased donors and help match them to patients on the nation’s transplant waiting list.

    The administration cited an investigation that found a 2024 case where an unspecified mistake led a surgeon to decline a donated heart for a patient awaiting surgery.

    In a news briefing, Dr. Mehmet Oz, who heads the Centers for Medicare and Medicaid Services, said problems included would-be donations that went unrecovered, sending some donated organs to the wrong place and a lack of staff.

    Life Alliance, a division of the University of Miami Health System, can appeal the decision. If it is shut down, it would mark the first time the federal government has decertified an OPO.

    Life Alliance didn’t immediately respond to a request for comment.

    More than 100,000 Americans are on the transplant list and thousands die waiting because there aren’t enough donations to go around. Last year there were more than 48,000 transplants, a record, the vast majority from deceased donors.

    Changes to the transplant system have been underway for years to increase donations, reduce waste of potentially usable organs and address other concerns. They include some new safeguards after complaints last year that a different OPO didn’t stop donation preparations quickly enough when some patients showed signs of life, prompting some people to opt out of donor registries. Organ donation can proceed only after a hospital has declared someone dead — and by law, OPOs cannot be involved in that decision.

    On Thursday, Oz sought to reassure would-be donors.

    “Congress has thoughtfully and aggressively pursued some horrifying stories that have chilled some Americans’ enthusiasm for donating organs. We are here today to tell you this system is safe. It’s rigorously being addressed,” he said, adding later, “I want to applaud the OPOs that are doing a great job because most are.”

    —-

    The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

    Source link

  • She was too sick for a traditional transplant. So she received a pig kidney and a heart pump

    She was too sick for a traditional transplant. So she received a pig kidney and a heart pump

    NEW YORK — Doctors have transplanted a pig kidney into a New Jersey woman who was near death, part of a dramatic pair of surgeries that also stabilized her failing heart.

    Lisa Pisano’s combination of heart and kidney failure left her too sick to qualify for a traditional transplant, and out of options. Then doctors at NYU Langone Health devised a novel one-two punch: Implant a mechanical pump to keep her heart beating and days later transplant a kidney from a genetically modified pig.

    Pisano is recovering well, the NYU team announced Wednesday. She’s only the second patient ever to receive a pig kidney — following a landmark transplant last month at Massachusetts General Hospital – and the latest in a string of attempts to make animal-to-human transplantation a reality.

    This week, the 54-year-old grasped a walker and took her first few steps.

    “I was at the end of my rope,” Pisano told The Associated Press. “I just took a chance. And you know, worst case scenario, if it didn’t work for me, it might have worked for someone else and it could have helped the next person.”

    Dr. Robert Montgomery, director of NYU Langone Transplant Institute, recounted cheers in the operating room as the organ immediately started making urine.

    “It’s been transformative,” Montgomery said of the experiment’s early results.

    But “we’re not off the hook yet,” cautioned Dr. Nader Moazami, the NYU cardiac surgeon who implanted the heart pump.

    “With this surgery I get to see my wife smile again,” Pisano’s husband Todd said Wednesday.

    Other transplant experts are closely watching how the patient fares.

    “I have to congratulate them,” said Dr. Tatsuo Kawai of Mass General, who noted that his own pig kidney patient was healthier overall going into his operation than NYU’s patient. “When the heart function is bad, it’s really difficult to do a kidney transplant.”

    More than 100,000 people are on the U.S. transplant waiting list, most who need a kidney, and thousands die waiting. In hopes of filling the shortage of donated organs, several biotech companies are genetically modifying pigs so their organs are more humanlike, less likely to be destroyed by people’s immune system.

    NYU and other research teams have temporarily transplanted pig kidneys and hearts into brain-dead bodies, with promising results. Then the University of Maryland transplanted pig hearts into two men who were out of other options, and both died within months.

    Mass General’s pig kidney transplant last month raised new hopes. Kawai said Richard “Rick” Slayman experienced an early rejection scare but bounced back enough to go home earlier this month and still is faring well five weeks post-transplant. A recent biopsy showed no further problems.

    Pisano is the first woman to receive a pig organ — and unlike with prior xenotransplant experiments, both her heart and kidneys had failed. She went into cardiac arrest and had to be resuscitated before the experimental surgeries. She’d gotten too weak to even play with her grandchildren. “I was miserable,” the Cookstown, New Jersey, woman said.

    A failed heart made her ineligible for a traditional kidney transplant. But while on dialysis, she didn’t qualify for a heart pump, called a left ventricular assist device or LVAD, either.

    “It’s like being in a maze and you can’t find a way out,” Montgomery explained — until the surgeons decided to pair a heart pump with a pig kidney.

    With emergency permission from the Food and Drug Administration, Montgomery chose an organ from a pig genetically engineered by United Therapeutics Corp. so its cells don’t produce a particular sugar that’s foreign to the human body and triggers immediate organ rejection.

    Plus a tweak: The donor pig’s thymus gland, which trains the immune system, was attached to the donated kidney in hopes that it would help Pisano’s body tolerate the new organ.

    Surgeons implanted the LVAD to power Pisano’s heart on April 4, and transplanted the pig kidney on April 12. There’s no way to predict her long-term outcome but she’s shown no sign of organ rejection so far, Montgomery said. And in adjusting the LVAD to work with her new kidney, Moazami said doctors already have learned lessons that could help future care of heart-and-kidney patients.

    Special “compassionate use” experiments teach doctors a lot but it will take rigorous studies to prove if xenotransplants really work. What happens with Pisano and Mass General’s kidney recipient will undoubtedly influence FDA’s decision to allow such trials. United Therapeutics said it hopes to begin one next year.

    ___

    The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

    Source link

  • A Temple Hospital worker needed a kidney transplant. When the call finally came, his colleague performed it

    A Temple Hospital worker needed a kidney transplant. When the call finally came, his colleague performed it

    Julian Harmon assists doctors, nurses and patients in the operating rooms where organ transplants are performed at Temple University Hospital.

    Harmon also has lived with kidney disease for nearly a decade and was put on the kidney transplant waiting list in 2019. Of the more than 90,000 Americans waiting for a kidney, only 28,144 received one in 2023.


    But every day at work, Harmon remained hopeful as he cleaned operating rooms, took specimens to labs and transported patients in and out of surgeries. 

    “I would even meet people who were going to get a kidney transplant,” said Harmon, who works as a perioperative services assistant.

    Instead of making him feel jealous or resentful, Harmon said talking to others as he wheeled them into operating rooms for transplant surgery helped him maintain hope. “I knew I wasn’t alone,” he said. “I always knew I would get the surgery done.”

    On Jan. 6, 2023, Harmon received a call at work that a kidney was available for him. Within hours, Harmon was in one of the operating rooms where he spends his days, receiving a life-saving transplant performed by Dr. Kenneth Chavin, director of Temple Health’s Abdominal Organ Transplant Program, whose locker happens to sit right next to Harmon’s.

    “Now we’ve become friends,” Chavin said. “He’s maintaining his kidney beautifully.”

    Earlier in April, Harmon and Chavin threw out the first pitch at a Phillies game. Their appearance was a way to celebrate and raise awareness about kidney donation during National Donate Life Month.

    Kidney disease is the fastest-growing noncommunicable disease in the United States and kills more people each year than breast or prostate cancer. About 37 million Americans are living with kidney disease, including 808,000 with kidney failure. 

    Black Americans are more than four times as likely to develop kidney failure than white Americans. Hispanic and Native Americans are more than twice as likely. 

    The shortage of available kidneys means that the majority of people living with kidney failure – which has no cure – are on dialysis while they hope for a kidney transplant. More than 556,000 people are on kidney dialysis, according to the American Kidney Fund.

    Harmon eventually ended up on dialysis after being diagnosed in 2015 with IgA nephropathy, a disease in which IgA protein builds up in and damages the filtering part of the kidney. For about four years, Harmon had to do peritoneal dialysis at home for 12 hours each night. The process which required him to attach a catheter surgically placed in his abdomen to a machine that pumped cleansing fluid into his stomach and waste products from his blood.

    “I would come home, make myself dinner, wash up and hook myself onto the machine,” Harmon said. “Some nights would be good, and some nights I would end up lying the wrong way and all sorts of alarms would go off.”

    His mother and his tight group of friends kept his spirits up. “I knew I had people in my corner,” Harmon said.

    “I used to work through the week and by the weekend I would be exhausted,” Harmon said. Often he had to rest in bed most of the weekend to regain the strength to return to work the following week.

    His mother worried about him, Harmon said. “To see me from there to now – she’s just ecstatic.

    “When you’re doing dialysis, there are a lot of things you have to sacrifice,” such as a social life, said Harmon, who now has a girlfriend.

    Receiving a kidney transplant is “transformational,” Chavin said, noting that it allows people to “go back to normal activity.”

    With more research and knowledge about the immune system and medication, one-year survival rates after a kidney transplant are now about 90%, Chavin said. In the early days of transplant surgery, they were closer to 50%.

    Someone who donates a kidney and then needs a transplant for whatever reason goes to the “top of the list,” Chavin said, “so the system has this safety net.”

    Donating organs not only impacts the people who receive them, but also “their legacy, what they do in life,” Chavin said.

    By sharing his story, Harmon said he hopes more people will consider organ donation. 

    “There are a lot of people in my situation,” Harmon said, “A lot of people who deserve that second chance at life.”



    People can register to be an organ donor when renewing their driver’s licenses or state IDs. They also can register online.

    Courtenay Harris Bond

    Source link

  • He Got a Pig Kidney Transplant. Now Doctors Need to Keep It Working

    He Got a Pig Kidney Transplant. Now Doctors Need to Keep It Working

    Other than rejection of the organ, one of the most common transplant complications is infection. Doctors have to strike a balance when prescribing immunosuppressive drugs: too low a dose can lead to rejection, while too much can make a patient vulnerable to infection. Immunosuppressants are powerful drugs that can cause a range of side effects, including fatigue, nausea, and vomiting.

    Despite the deaths of the two pig heart recipients, Riella is optimistic about Slayman’s transplant. For one, he says, Slayman was relatively healthy when he underwent the surgery. He qualified for a human kidney but because of his rare blood type he would likely need to wait six to seven years to get one. The two individuals who received pig heart transplants were so ill that they didn’t qualify for a human organ.

    In addition to close monitoring and traditional immunosuppressants, Slayman’s medical team is treating him with an experimental drug called tegoprubart, developed by Eledon Pharmaceuticals of Irvine, California. Given every three weeks via an IV, tegoprubart blocks crosstalk between two key immune cells in the body, T cells and B cells, which helps suppress the immune response against the donor organ. The drug has been used in monkeys that have received gene-edited pig organs.

    Photograph: Massachusetts General Hospital

    “It’s pretty miraculous this man’s out of the hospital a couple of weeks after putting in a pig kidney,” says Steven Perrin, Eledon’s president and chief scientific officer. “I didn’t think we would be here as quickly as we are.”

    Riella is also hopeful that the 69 genetic alterations made to the pig that supplied the donor organ will help Slayman’s kidney keep functioning. Pig organs aren’t naturally compatible in the human body. The company that supplied the pig, eGenesis, used Crispr to add certain human genes, remove some pig genes, and inactivate latent viruses in the pig genome that could hypothetically infect a human recipient. The pigs are produced using cloning; scientists make the edits to a single pig cell and use that cell to form an embryo. The embryos are cloned and transferred to the womb of a female pig so that her offspring end up with the edits.

    “We hope that this combination will be the secret sauce to getting this kidney to a longer graft survival,” Riella says.

    There’s debate among scientists over how many edits pig organs need to last in people. In the pig heart transplants, researchers used donor animals with 10 edits developed by United Therapeutics subsidiary Revivicor.

    There’s another big difference between this procedure and the heart surgeries: If Slayman’s kidney did stop working, Riella says, he could resume dialysis. The pig heart recipients had no back-up options. He says even if pig organs aren’t a long-term alternative, they could provide a bridge to transplant for patients like Slayman who would otherwise spend years suffering on dialysis.

    “We’ve gotten so many letters, emails, and messages from people volunteering to be candidates for the xenotransplants, even with all the unknowns,” Riella says. “Many of them are struggling so much on dialysis that they’re looking for an alternative.”

    The Mass General team plans to launch a formal clinical trial to transplant edited pig kidneys in more patients. They received special approval from the US Food and Drug Administration for just one procedure. For now, though, their main focus is on keeping Slayman healthy.

    Emily Mullin

    Source link

  • This Bag of Cells Could Grow New Livers Inside of People

    This Bag of Cells Could Grow New Livers Inside of People

    In early experiments, Lagasse found that if he injected healthy liver cells into the lymph nodes of mice, the cells would flourish and form a second, smaller liver to take over the functions of the animal’s failing one. The new livers grew up to 70 percent of the size of a native liver. “What happened is that the liver grew to a certain size and then stopped growing when it reached the level necessary for normal function,” Lagasse says.

    At the University of Pittsburgh, Lagasse and his colleagues also tested the approach in pigs. In a study published in 2020, they found that pigs regained liver function after getting an injection of liver cells into an abdominal lymph node. When the scientists examined the lymph nodes with miniature livers, they found that a network of blood vessels and bile ducts had spontaneously formed. The more severe the damage in the pigs’ native liver, the bigger the second livers grew, suggesting the animals’ bodies may be able to recognize the healthy liver tissue and transfer responsibilities to it.

    “It is remarkable to identify lymph nodes as a reproducible and fertile bed for the regeneration of a variety of tissues and organs in two different animal species,” Abla Creasey, vice president of therapeutics development at the California Institute for Regenerative Medicine, says of the company’s approach. “These findings suggest that such an approach could present an alternative tissue source for patients with failing organs,”

    Elliot Tapper, a liver specialist at the University of Michigan, is also excited by the prospect of turning a lymph node into a new liver. “Even though it’s not where the liver was intended to sit, it can still do some liver functions,” he says.

    The most likely benefit of the LyGenesis treatment, he says, would be removing ammonia from the blood. In end-stage liver disease, ammonia can build up and travel to the brain, where it causes confusion, mood swings, falls, and sometimes comas. He doesn’t think the new mini organs could do all the jobs of a natural liver though, because they contain cell types other than hepatocytes.

    One of the big questions is how many cells it will require for humans to grow a liver big enough to take over certain vital functions, such as filtering blood and producing bile. In the LyGenesis trial, three additional patients will get an injection of 50 million cells into a single lymph node—the lowest “dose.” If that seems safe, a second group of four will get 150 million cells into three different lymph nodes. A third group would get 250 million cells in five lymph nodes—meaning they could have five mini livers growing inside them.

    The effects of the therapy won’t be immediate. Hufford says it will likely take two to three months for the new organ to grow big enough to take over some of the functions of the native liver. And like organ donor recipients, trial participants will need to go on immunosuppressant drugs for the rest of their lives to prevent their body from rejecting the donor cells.

    If the approach works, it could provide a life-saving alternative to liver transplantation for some patients. “If they prove it’s effective and safe,” Tapper says, “there will definitely be candidates that are interested in this kind of intervention.”

    Emily Mullin

    Source link

  • A Gene-Edited Pig Kidney Was Just Transplanted Into a Person for the First Time

    A Gene-Edited Pig Kidney Was Just Transplanted Into a Person for the First Time

    Slayman received his first kidney transplant in 2018 from a human donor. The donor kidney initially functioned well, but Slayman started to go into kidney failure after years of living with diabetes. Diabetes is the leading cause of kidney disease, which can eventually result in kidney failure.

    He had no choice but to go on dialysis, a treatment that removes excess fluid and waste from a person’s blood. But the dialysis caused complications—his blood vessels were clotting and failing. Slayman wound up in the hospital regularly and endured dozens of procedures to try to fix the problem.

    “Slowly but surely, I witnessed my patient becoming increasingly despondent and depressed over his dialysis situation,” Winfred Williams, a kidney specialist and member of Slayman’s medical team, said on Thursday.

    Finally, Williams suggested a pig kidney transplant. Slayman agreed. “I saw it not only as a way to help me, but a way to provide hope for the thousands of people who need a transplant to survive,” Slayman said in a statement released by Massachusetts General Hospital.

    The procedure was performed under the Food and Drug Administration’s “compassionate use” pathway, which allows a patient with a life-threatening condition to access an experimental treatment when no other options exist. Slayman is also receiving an infusion of novel immunosuppressant drugs to prevent rejection of the organ. His medical team is currently monitoring his kidney function using ultrasound.

    The Massachusetts team thinks the ideal candidate for a pig kidney will be a patient who was approved for a regular human kidney transplant but has a long wait time for a donor.

    The pig kidney transplant comes on the heels of a procedure in January, in which surgeons at the University of Pennsylvania successfully attached a gene-edited pig liver to a braindead person and found that the organ functioned normally for 72 hours. The liver, also from eGenesis, contained the same 69 edits as Slayman’s kidney.

    The liver is a more complicated organ because of the many functions it performs, so researchers don’t think pig livers are ready to be used in place of human ones just yet. Instead, they could be used outside the body and connected to patients who are waiting for a human organ or those who need temporary support while their own liver recovers.

    Researchers have been working up to transplanting a modified pig kidney in a person. Last year, eGenesis reported that a kidney from one of its edited pigs functioned in a monkey for more than two years. And scientists at New York University and the University of Alabama at Birmingham have transplanted gene-edited pig kidneys into braindead patients to observe how well the organs function.

    Jayme Locke, an abdominal transplant surgeon at the University of Alabama at Birmingham who has overseen some of those experiments, was thrilled to hear about the Boston kidney transplant. “This is wonderful news, and it’s great to see it move into the clinic,” she told WIRED in an interview.

    Locke says the recent flurry of xenotransplantation experiments shows that the idea of using pig organs in people is gaining momentum and is here to stay. “I think it really has staying power and it’s going to really revolutionize the field and hopefully offer organs to all those in need,” she says.

    Locke’s team is also looking to do pig-to-human kidney transplants. She said she has several patients in mind for the procedures and is just waiting on the FDA to give the greenlight. “We’re ready to go.”

    Emily Mullin

    Source link

  • Dutch photographer Erwin Olaf has died at 64. He shot themes from gay nightlife to the royal family

    Dutch photographer Erwin Olaf has died at 64. He shot themes from gay nightlife to the royal family

    Acclaimed Dutch photographer Erwin Olaf has died at age 64

    ByMIKE CORDER Associated Press

    September 20, 2023, 3:08 PM

    THE HAGUE, Netherlands — Erwin Olaf, an acclaimed Dutch photographer whose work documented topics ranging from gay nightlife in Amsterdam to portraits of the Dutch royal family, has died. He was 64.

    Olaf’s highly stylized photos, with lighting often influenced by Dutch master painters Rembrandt van Rijn and Johannes Vermeer, were exhibited at galleries around the world during a career spanning decades.

    His website carried a statement saying that Olaf recently underwent a lung transplant.

    “The recovery seemed to be going very well. He suddenly became unwell on Wednesday morning and CPR was to no avail. We’re going to miss him terribly,” it added.

    Taco Dibbits, director of the Rijksmuseum, paid tribute in a statement on the Amsterdam museum’s website.

    “Erwin Olaf saw beauty in every person,” Dibbits said. He said Olaf was of “historical importance” because of his activism and role in the LGBTQ+ community.

    He called Olaf “an artist with enormous drive and with a very great eye for detail. The Rijksmuseum received its core collection in 2018 and considered Erwin Olaf a sincere friend. We’ll miss him.”

    Olaf was made a Knight of the Order of the Lion of the Netherlands after 500 of his works were added to the Rijksmuseum collection.

    He worked in advertising — once portraying nuns in jeans for a clothing company — as well as in the world of high art and portraiture.

    Over the years, he shot portraits of King Willem-Alexander and his family and in 2013 he designed the Dutch side of a new euro coin bearing an image of the king when Willem-Alexander acceded to the throne.

    In March, Willem-Alexander awarded Olaf with the Dutch Royal House’s Medal of Honor for Art and Science. It honored him for “using a daring approach to portraiture to address themes such as ethnicity, sexual diversity and economic inequality.”

    In a reaction to his death, King Willem-Alexander and Queen Maxima said the Netherlands “has lost a unique, exceptionally talented photographer and a great artist.”

    “We will miss his friendship,” they added in a statement posted on social media. “His work lives on and continues to be intriguing and moving.”

    Source link

  • How a family’s choice to donate a body for pig kidney research could help change transplants

    How a family’s choice to donate a body for pig kidney research could help change transplants

    NEW YORK — Mary Miller-Duffy was dazed and grieving. Her brother suddenly collapsed and days later was brain-dead. Now she faced a tough question: Would she donate his body for research?

    That’s how the body of Maurice “Mo” Miller started its journey to a sunny corner of NYU Langone Health’s intensive care unit — and became part of the quest to one day ease the nation’s transplant shortage with organs from animals.

    “He always wanted to help people,” said Miller-Duffy, who struggled with the choice but is proud of her brother’s last act. “This tragic death, this fast short death — something good has come out of it.”

    Surgeons replaced Miller’s kidneys with one from a genetically modified pig on July 14. Then doctors and nurses cared for the deceased man like they would a living patient while anxiously ticking off the days.

    Remarkably, over a month later the new organ is performing all the bodily functions of a healthy kidney — the longest a pig kidney has ever worked in a person. Now the countdown is on to see if the kidney can last into September, a second month.

    The Associated Press got an inside look at the challenges of experiments with the dead that may help bring animal-to-human transplants closer to reality.

    ___

    Getting an organ transplant today is a long shot. More than 100,000 people are on the national waiting list, most who need a kidney. Thousands die waiting. Thousands more who could benefit aren’t even added to the list.

    “I had seven cardiac arrests before I even was sick enough” to qualify for a new heart, said Dr. Robert Montgomery, chief of NYU Langone’s transplant institute. He’s a kidney transplant surgeon — and was lucky enough to get his own heart transplant in 2018.

    Filling the gap, he’s convinced, will require using animal organs.

    After decades of failed attempts, now pigs genetically modified so their organs are more humanlike are renewing interest in so-called xenotransplantation. Last year, University of Maryland surgeons tried to save a dying man with a pig heart — and he survived for two months.

    Montgomery is getting more practice in the dead before taking a chance with a living patient. A handful of prior experiments at NYU and the University of Alabama at Birmingham have kept pig kidneys and hearts working in donated bodies for a few days to a week, avoiding the immediate rejection that doomed many earlier attempts.

    But the most common kind of organ rejection develops over a month. That pig heart in Maryland worked great for nearly 50 days until abruptly faltering. Watching how pig kidneys reach those timepoints in donated bodies could offer vital lessons — but how long could Montgomery expect a family to turn over their loved one?

    “I’m in awe of someone who can make a decision like that at, you know, one of the worst moments in their lives and really think about … humanity,” he said.

    ____

    In Newburgh, New York, an ambulance had raced Miller to the hospital after he collapsed, a mass in his brain. He never woke up from the biopsy, brain-dead at just 57. Next steps were up to his sister, his closest relative.

    Miller-Duffy asked about donating his organs but he didn’t qualify. That biopsy had found cancer.

    Only then did the organ agency broach whole-body donation. Miller-Duffy wasn’t familiar with that, but the goal of improving kidney transplants, “that kind of struck a chord.” Another brother had died of kidney disease as a toddler. Other relatives have kidney-damaging illnesses or even died on dialysis.

    Flipping through family photos, Miller-Duffy recalled how her brother would adopt animals and once took care of a terminally ill friend. Still, she had questions.

    In a video call, Montgomery explained the pig transplant to Miller-Duffy and her wife, Sue Duffy — and why it could make a difference. Montgomery’s compassion won them over.

    “His body is not being hurt, you know,” Duffy said. “It’s just an incubation for the study to be done.”

    ____

    The experiment served as a rehearsal for one day operating in a living patient. Montgomery finished removing Miller’s own kidneys as a helicopter headed for the hospital’s riverside landing pad. Drs. Jeffrey Stern and Adam Griesemer, fellow NYU surgeons, raced in kidneys they’d removed from a pig bred by Blacksburg, Virginia-based Revivicor.

    Sewing a pig kidney into a donated body isn’t much different than a regular transplant, Stern said. Post-surgery immune-suppressing drugs are standard, too.

    One twist: Tacked onto the pig’s kidney was its thymus, a gland that trains immune cells — and thus might help protect the organ.

    Lots of extra steps come before and after surgery.

    First, what pig to use: Some have up to 10 genetic changes but Montgomery is betting one is enough — removal of a single porcine gene that triggers an immediate immune attack.

    While the pigs are housed in a germ-free facility, researchers performed extra testing for any hidden infection. Everyone in the operating room must have certain vaccinations and undergo blood tests of their own.

    Surgery over, doctors wheeled Miller’s body into the same ICU room where five years earlier Montgomery had recovered from his heart transplant.

    Next came more intense testing than living patients could tolerate. Every week doctors biopsy the kidney, putting samples under the microscope to spot any hints of rejection. Blood is continually monitored, the spleen got a peek, and nurses keep close watch that the body is being properly maintained on the ventilator.

    The first few weeks, Griesemer checked lab test results and vital signs multiple times a day: “You’re like, OK, hopefully things are still good — but is this the day it starts to turn?”

    And they’re shipping biopsy samples to research partners across the country and as far away as France.

    “Our staff doesn’t sleep that much,” said Elaina Weldon, a nurse practitioner who oversees the transplant research. But with each passing week, “everybody is really now at the point of, what more can we do? How far can we push?”

    She knows firsthand the huge interest: NYU quizzed community groups and religious leaders before embarking on research with donated bodies that might have sounded “a little bit more on the sci-fi side of things.”

    Instead, many people wanted to know how soon studies in the living could start, something the Food and Drug Administration will have to decide. Dozens have written Montgomery, eager to participate.

    ___

    Montgomery regularly calls Miller-Duffy and her wife with updates, and invited them to NYU to meet the team. And as the study’s initial one-month deadline approached, he had another ask: It was going so well, could they keep her brother’s body for a second month?

    It meant further postponing plans for a memorial service but Miller-Duffy agreed. Her request: That she gets to be there when her brother is finally disconnected from the ventilator.

    Whatever happens next, the experiment has changed Sue Duffy’s outlook on organ donation.

    “Maybe I don’t need all my organs when I go to heaven,” she said. “Before I was a hard no. … Now I’m a hard yes.”

    ___

    The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

    Source link

  • Pig kidney works in a donated body for over a month, a step toward animal-human transplants

    Pig kidney works in a donated body for over a month, a step toward animal-human transplants

    NEW YORK — Surgeons transplanted a pig’s kidney into a brain-dead man and for over a month it’s worked normally — a critical step toward an operation the New York team hopes to eventually try in living patients.

    Scientists around the country are racing to learn how to use animal organs to save human lives, and bodies donated for research offer a remarkable rehearsal.

    The latest experiment announced Wednesday by NYU Langone Health marks the longest a pig kidney has functioned in a person, albeit a deceased one -– and it’s not over. Researchers are set to track the kidney’s performance for a second month.

    “Is this organ really going to work like a human organ? So far it’s looking like it is,” Dr. Robert Montgomery, director of NYU Langone’s transplant institute, told The Associated Press.

    “It looks even better than a human kidney,” Montgomery said on July 14 as he replaced a deceased man’s own kidneys with a single kidney from a genetically modified pig — and watched it immediately start producing urine.

    The possibility that pig kidneys might one day help ease a dire shortage of transplantable organs persuaded the family of Maurice “Mo” Miller from upstate New York to donate his body for the experiment. He’d died suddenly at 57 with a previously undiagnosed brain cancer, ruling out routine organ donation.

    “I struggled with it,” his sister, Mary Miller-Duffy, told the AP about her decision. But he liked helping others and “I think this is what my brother would want. So I offered my brother to them.”

    “He’s going to be in the medical books, and he will live on forever,” she added.

    Attempts at animal-to-human transplants, or xenotransplantation, have failed for decades as people’s immune systems attacked the foreign tissue. Now researchers are using pigs genetically modified so their organs better match human bodies.

    Last year with special permission from regulators, University of Maryland surgeons transplanted a gene-edited pig heart into a dying man who was out of other options. He survived only two months before the organ failed for reasons that aren’t fully understood but that offer lessons for future attempts.

    Next, rather than last-ditch efforts, the Food and Drug Administration is considering whether to allow some small but rigorous studies of pig heart or kidney transplants in volunteer patients.

    The NYU experiment is one of a string of developments aimed at speeding the start of such clinical trials. Also Wednesday, the University of Alabama at Birmingham reported another important success — a pair of pig kidneys worked normally inside another donated body for seven days.

    Kidneys don’t just make urine — they provide a wide range of jobs in the body. In the journal JAMA Surgery, UAB transplant surgeon Dr. Jayme Locke reported lab tests documenting the gene-modified pig organs’ performance. She said the weeklong experiment demonstrates they can “provide life-sustaining kidney function.”

    These kinds of experiments are critical to answer remaining questions “in a setting where we’re not putting someone’s life in jeopardy,” said Montgomery, the NYU kidney transplant surgeon who also received his own heart transplant — and is acutely aware of the need for a new source of organs.

    More than 100,000 patients are on the nation’s transplant list and thousands die each year waiting.

    Maryland’s Dr. Muhammad Mohiuddin cautions that it’s not clear how closely a deceased body will mimic a live patient’s reactions to a pig organ. But he said the research educates the public about xenotransplantation so “people will not be shocked” when it’s time to try again in the living.

    Previously, NYU and a team at the University of Alabama at Birmingham had tested pig kidney transplants in deceased recipients for just two or three days. An NYU team also had transplanted pig hearts into donated bodies for three days of intense testing.

    But how do pig organs react to a more common human immune attack that takes about a month to form? Only longer testing might tell.

    The surgery itself isn’t that different from thousands he’s performed “but somewhere in the back of your mind is the enormity of what you’re doing … recognizing that this could have a huge impact on the future of transplantation,” Montgomery said.

    The operation took careful timing. Early that morning Drs. Adam Griesemer and Jeffrey Stern flew hundreds of miles to a facility where Virginia-based Revivicor Inc. houses genetically modified pigs — and retrieved kidneys lacking a gene that would trigger immediate destruction by the human immune system.

    As they raced back to NYU, Montgomery was removing both kidneys from the donated body so there’d be no doubt if the soon-to-arrive pig version was working. One pig kidney was transplanted, the other stored for comparison when the experiment ends.

    One other trick: Surgeons attached the pig’s thymus to the transplanted kidney in hopes that the gland, which helps train immune cells, would increase human tolerance of the organ. Otherwise, the team is relying on standard immune-suppressing drugs used by today’s transplant patients.

    “You’re always nervous,” Griesemer said. To see it so rapidly kickstart, “there was a lot of thrill and lot of sense of relief.”

    How long should these experiments last? Alabama’s Locke said that’s not clear -– and among the ethical questions are how long a family is comfortable or whether it’s adding to their grief. Because maintaining a brain-dead person on a ventilator is difficult, it’s also dependent on how stable the donated body is.

    In her own experiment, the donated body was stable enough that if the study wasn’t required to end after a week, “I think we could have gone much longer, which I think offers great hope,” she said.

    ___

    AP video journalist Shelby Lum contributed to this report.

    ___

    The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

    Source link

  • Indonesian police crack down on traffickers who sent 122 people to sell their kidneys in Cambodia

    Indonesian police crack down on traffickers who sent 122 people to sell their kidneys in Cambodia

    JAKARTA, Indonesia — Indonesian police are investigating the illegal trade of human organs involving police and immigration officers who were accused of helping traffickers send 122 Indonesians to a hospital in Cambodia to sell their kidneys, police said Tuesday.

    Indonesian authorities arrested 12 people, including a police officer and an immigration officer, on July 19, and police will continue to crack down on human smuggling syndicates conducting the illegal trade of human organs, said Hengki Haryadi, the Jakarta police director for general crimes.

    He said all 122 victims, including factory workers, teachers and executives, had returned to Indonesia, and police were still searching a number of other victims whose testimony would be required by investigators.

    “Most of the victims lost their jobs during the pandemic and they agreed to sell their organs because they needed money,” Haryadi said, adding that six of the victims are still under observation of doctors.

    Nine of the suspects were former organ trade victims who were accused of luring people from across Indonesia through social media into having their kidneys removed in Cambodia, Haryadi said. A 10th suspect was accused of sending them to Preah Ket Mealea Hospital in Cambodia’s capital, Phnom Penh, for kidney transplant surgery.

    He said the turnover of the illegal trade in human organs since 2019 by the group of suspects totaled about 24.4 billion rupiah ($1.6 million), while each victim was promised 135 million rupiah ($9,000) .

    A low-ranking police officer in Bekasi, an immigration officer in Bali and 10 traffickers, three of whom were arrested in Cambodia, are part of a human trafficking ring that prey on vulnerable job seekers, Haryadi said.

    The immigration officer from Bali was accused of abusing his power and falsifying documents for victims to travel overseas and received at least 3 million rupiah ($200) for each person he smuggled to Cambodia.

    The suspects were charged with violating Indonesia’s human trafficking law and face a maximum 15 years in prison and a fine of up to 600 million rupiah ($39,000).

    The police officer from Bekasi city police, identified only with the initial M., allegedly received 612 million rupiah ($40,000) for helping the traffickers move from place to place to avoid police investigation, and he is also accused of obstructing the investigation. Under the 2007 Human Trafficking Law, the two officers face penalties of up to five years in prison if found guilty.

    Police paraded the 12 suspects at a news conference on July 20.

    “There have been kidney trafficking transactions at the Cambodia’s state-run Preah Ket Mealea Hospital,” said Krishna Murti, the National Police head of international relations division. “We have been communicating and closely cooperating with the Cambodian police.”

    The World Health Organization first prohibited payments for organs in 1987 and many countries subsequently codified the prohibition into their national laws. WHO estimated in 2008 that 5% of all transplants performed worldwide were illegal, and living donor kidneys is the most commonly reported form of organ trade.

    Aside illegal trade in human organs, cybercrime, human trafficking and labor abuse still abounds in Southeast Asia. Most recently, authorities in the Philippines staged a major raid last month and rescued more than 2,700 workers from China, the Philippines, Vietnam, Indonesia and more than a dozen other countries who were allegedly swindled into working for fraudulent online gaming sites and other cybercrime groups.

    The leaders of Association of Southeast Asia Nations in a summit at Indonesia’s Labuan Bajo in May agreed to increase cooperation in border management, investigation, law enforcement and prosecution, and repatriation of victims. They also urged that national prevention efforts be improved, including better public awareness campaigns and increased use of advanced technology.

    Source link

  • Ticks’ Secret Weapon

    Ticks’ Secret Weapon

    In the three-plus decades I’ve been alive, I have never been bitten by a tick. Actually, that may be a lie, and I have no way of knowing for sure. Because even though ticks have harpoonlike mouthparts, even though certain species can latch on for up to two weeks, even though some guzzle enough blood to swell 100 times in weight, their bites are disturbingly discreet. “As a kid, I would have hundreds of ticks on me,” at least several of which would bite, says Adela Oliva Chavez, a tick researcher at Texas A&M University. And yet she would never notice until her aunt would pick them off her skin.

    The secret behind tick stealth is tick saliva—a strange, slippery, and multifaceted fluid with no biological peer. It keeps the pests’ bites bizarrely itch- and pain-free, and allows them to feed unimpeded by their hosts’ immunity. As climate change remodels the world, spit is also what’s helping ticks enter new habitats and hosts—bringing with them the many deadly viruses, bacteria, and parasites they so often import.

    For all their dependency on blood, ticks almost never eat. In their sometimes-multiyear life span, they may feed only once in each stage: larva, nymph, and adult. Which means, as my colleague Sarah Zhang once wrote, each meal must count for an awful lot. Unlike mosquitoes and other bloodsucking bugs that can get away with a dine and dash, ticks must linger on flesh for days or even weeks—an extended feast that requires them to essentially graft onto the host’s body like a temporary limb.

    For the entirety of that process, saliva is key. When a tick first bites, its spit lines the wound with a gluelike substance that cements its mouth in place. Once secure, the tick deploys a fleet of spit-borne compounds that dilate its host’s vessels, while simultaneously battling the bodily compounds that would normally prompt the injury to clot, heal, or tingle with pain or itch. Under most circumstances, such an onslaught of foreign molecules would instantly marshal the body’s immune cavalry. But ticks have workarounds for that too. Their saliva is an anti-inflammatory and an analgesic; it can disable the alarms that cells send to one another, preventing them from coordinating an attack. Spit can even reprogram immune cells so that they never complete their development or receive the cues they need to gather at the scene.

    All of these strategies can also ease the way for bacteria, viruses, and parasites that the tick swallows from one host, then deposits into the next. With tick saliva breaching the skin barrier and keeping the immune system in check, all the pathogens have to do is come along for the ride. “Tick saliva is like a luxury vehicle that delivers them to the site of infection and rolls out the red carpet,” says Seemay Chou, the CEO of the biotech start-up Arcadia Science. Studies have shown that multiple pathogens get an infectious boost when chauffeured by spit, spilling more efficiently into the skin of newly bitten hosts. Borrelia burgdorferi, the bacterium that causes Lyme disease, will even slather parts of tick saliva onto itself like a cloak, essentially rendering itself invisible to bodily defense. Ticks’ infectious cargo may even egg each other on: Saravanan Thangamani, at Upstate Medical University, in New York, has found evidence that ticks simultaneously carrying Borrelia and Powassan virus may end up injecting more of the latter into fresh wounds.

    Already, ticks spread more pathogens to humans and their livestock than any other insect or arachnid. And the risks ticks pose may only be growing, as warming temperatures and human meddling with wildlife allow them to expand their geographic range and infiltrate new hosts. In North America, lone-star ticks and black-legged ticks have been orchestrating a concerted march north into Canada. At the same time, the percentage of ticks carrying infections is also increasing, Thangamani told me, and for decades now, case counts of Lyme disease and tick-borne encephalitis in several parts of the world have been on a steady rise. As cold seasons shrink, the periods of the year when ticks bite—usually, the warmest months—are expanding too. “Many, many places are getting filled up with ticks,” says Jean Tsao, an entomologist at Michigan State University. “And they’re going to get more.”

    It helps that many ticks aren’t picky about whom they carry or bite. Some species, as they push into new places, have picked up new pathogens in the past few years—Bourbon virus, heartland virus—that pose additional threats to us. Many tick species are also relatively indiscriminate about their hosts: Within its lifetime, a single deer tick may “feed very happily on reptiles, avians, and birds,” says Pat Nuttall, a virologist and tick researcher at the University of Oxford. Their spit is intricate enough that it can be tailored to counteract the defenses of each species in turn. Transfer a tick from a rabbit to a human or a dog, Oliva Chavez told me, and it will take notice—and adjust its saliva, quite literally to taste.

    Vaccines to combat Lyme and other tick-borne diseases have long been in development. But many researchers think the more efficient tactic is going after the tick itself—a strategy that could, at best, “stop the transmission of several pathogens at once,” says Girish Neelakanta, a tick biologist at the University of Tennessee at Knoxville. Anti-tick immunity is possible: Studies have documented guinea pigs, cattle, rabbits, goats, and dogs developing sustained defenses against the arachnids after they’ve been bitten over and over again—even reactions that can help the animals detect a bite immediately, and sweep the pest away.

    But spit is a slippery target for bodily defenses to hit. The substance doesn’t just shut down immune responses. It also reformulates itself constantly so that it can keep evading the host’s defenses—as often as every few hours, faster than most of the immune system can keep track. By the time the body has prepped an assault on one salivary ingredient, the tick has almost certainly swapped it out for the next. “It’s a game that the tick is playing, a catch-me-if-you-can kind of thing,” says Sukanya Narasimhan, a tick researcher at Yale. To outcompete the tick’s tricks, Narasimhan thinks it will be key to develop a vaccine that triggers the body to respond to tick bites fast, “as soon as a tick attaches,” she said, ideally by targeting the saliva’s first ingredients.

    As ticks continue their takeover, it’s hard not to develop at least some grudging respect for their pluck. Some scientists even think that studying, or perhaps mimicking, their saliva could lead to other breakthroughs. Copycatting the spit’s immunosuppressive tendencies could be useful for the treatment of asthma, or for drugs that assist in organ transplants; imitating its anticoagulant properties could help keep life-threatening clots at bay. Some tick-saliva ingredients have even prompted investigations into their potential as cancer therapy. Ticks, after all, have been studying mammalian bodies for millions of years, all in hopes of subterfuge; under their tutelage, Chou, the Arcadia Science CEO, hopes to learn more about the molecular pathways that drive the urge to itch.

    Ticks aren’t invincible, though, and some of the same global changes now easing their entry into new habitats could eventually hinder their progress. Already, they are fleeing parts of the planet that have grown too hot, too humid, too flooded, too razed with wildfires for them or their preferred hosts to survive, including certain inhospitable pockets of the American South. A tick decline could be good for us. But it would also be a symptom of a planetary scourge that has grown worse. Ticks, undoubtedly, “will continue to adapt,” Thangamani told me. And yet they, too, have their limits—further, but not that much further, beyond our own.

    Katherine J. Wu

    Source link

  • Are you confronting a big medical bill? Attack it with a plan — and these tips

    Are you confronting a big medical bill? Attack it with a plan — and these tips

    An enormous medical bill can trigger a wave of panic, but try to resist.

    That startling invoice that arrived in the mail may not be what you wind up paying. Errors or slow insurance payments may have inflated the total. Even if it’s accurate, financial aid or other assistance might help pare it.

    Sometimes a simple phone call clears up a problem. Other times, reinforcements are necessary.

    Debt experts say patients should attack medical bills with a plan. Here are key steps to take.

    CHECK THE NUMBERS

    Don’t stash the bill in a pile of mail and hope it goes away, but don’t rush to pay it without first understanding the amount.

    “Especially if it’s a really high bill, consider it like an opening offer,” says Caitlin Donovan, a spokesperson for the nonprofit Patient Advocate Foundation, which helps critically or chronically ill patients deal with debt and insurance problems.

    Medical bills can be rife with errors. They also may have been sent before insurance coverage was sorted out.

    Donovan recommends comparing the bill with your insurer’s explanation of benefits. That’s a document the insurer sends that explains how your coverage will apply to the care you received. It can give you a sense for what you may still owe based on your deductible or the plan’s out-of-pocket maximum.

    If something looks weird, call both the insurer and hospital for an explanation.

    Someone at the hospital may have mistakenly entered the wrong code for the care you received or duplicated it. Request an itemized bill from the hospital to see if that happened.

    But be aware that those bills also can be hard to interpret or contain errors that have little to do with the charge, Donovan said.

    KNOW THE LAW

    The No Surprises Act debuted last year and offers a layer of protection. Patients should check to make sure their care provider is following that law.

    It prevents doctors or hospitals in many situations from billing insured patients higher rates when the care providers are not in their insurer’s coverage network.

    The law offers protection for most emergency care by basically requiring that patients receive in-network coverage with no additional billing from the provider. It also protects patients from huge bills for lab work or an out-of-network anesthesiologist when the patient was treated at an in-network hospital.

    The Centers for Medicare and Medicaid Services has established a “No Surprises Help Desk” for people who have questions about whether their bill complies with the law. They can call (800) 985-3059 or submit a complaint online.

    SEEK OUTSIDE HELP

    There are a host of for-profit and nonprofit organizations that can help people navigate medical bills.

    The Patient Advocate Foundation helped David White recoup more than $2,000 he paid for routine lab work after his kidney transplant.

    A case manager told White that a government database was causing complications with the claim, and this sort of thing had happened before to people with his condition. She also helped him file paperwork to correct the mistake.

    “Every single penny that I paid out was refunded,” said the 61-year-old White, a volunteer foundation board member. “There’s just no way I could figure this out on my own.”

    The foundation offers an online directory of potential resources for medical or prescription bill help.

    Outside help might also include a state attorney general’s office, which may have a health advocacy unit or a consumer protection division.

    Be very wary of any sort of medical credit card a provider may offer, said John McNamara, a principal assistant director with the federal Consumer Financial Protection Bureau. Those cards may come with high interest rates or terms that can hurt the patient financially if the debt isn’t fully paid in a certain time frame.

    Plus patients who jump at that offer may miss out on other financial assistance, or their insurer may not be billed, McNamara noted.

    FINANCIAL ASSISTANCE

    Once you have checked for errors, ask for financial assistance. Some hospital systems may provide help for people with income levels as high as six figures.

    “People a lot of times assume they won’t qualify,” Donovan said.

    Patients should be persistent in asking for help or finding out why an application was denied. That may have happened due to a mistake. Applications can ask for a lot of supporting documentation.

    Many hospitals don’t do a great job letting patients know about available help, said Marceline White, executive director of Economic Action Maryland, a non-profit that helps people in that state apply for financial assistance.

    “The onus is on the patient to apply for the assistance and do the work,” she said.

    Ask for a discount if no financial assistance is available.

    BARGAIN AND BUDGET

    You’ve checked for errors and asked about discounts and financial assistance. Now you may have to confront a final invoice.

    Ask about a payment plan. Many hospitals will offer options with no interest or a very low rate.

    But before committing to that, go over your budget to get a sense for what sort of payment you can handle. Consider looking for income-based programs that may be able to help with rent or utility bills.

    Donovan noted that people who agree to a monthly bill that turns out to be too high may wind up having that debt land in collections if they can’t make payments.

    “Then you’re in a whole new problem,” she said.

    ___

    The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

    Source link

  • Right-wing populist Javier Milei gains support in Argentina by blasting ‘political caste’

    Right-wing populist Javier Milei gains support in Argentina by blasting ‘political caste’

    BUENOS AIRES, Argentina — He believes selling human organs should be legal, climate change is a “socialist lie,” sex education is a ploy to destroy the family and that the Central Bank should be abolished. He also could be Argentina’s next president.

    Javier Milei, an admirer of former U.S. President Donald Trump, is the latest example of how right-wing populists are making inroads in Latin America, appealing to a citizenry angry with politics as usual and eager for outsiders to shake up the system.

    A libertarian economist and self-described “anarcho capitalist,” Milei made a name for himself by shouting against the “political caste” on television. His presidential candidacy looked like a sideshow until recently. Polls show his popularity rising, and his proposals dominate discussions ahead of October elections.

    “Today no one can say that Milei isn’t someone who could get to the presidency,” said Luis Tonelli, a political scientist at University of Buenos Aires.

    Milei jumped from talking head to politician in 2021 when he won a seat in Argentina’s lower house of Congress. Since then, he’s had little legislative activity, but 2.7 million people have signed up for his monthly raffle to give away his salary.

    On a recent Sunday, fans lined up at the Buenos Aires Book Fair to see him talk about his latest book, “The End of Inflation,” on addressing Argentina’s most pressing economic issue : inflation running at an annual rate of more than 100%. The book calls for cutting spending, abolishing the Central Bank and moving to the dollar.

    Many of his fans never made it inside. They’re mostly young men who treat the 52-year-old politician like a rock star and affectionately refer to him as “the wig” because of his signature unkempt hair.

    “The caste is afraid,” Milei said, and his followers chanted along.

    Afraid or not, the country’s political leaders now see him as real competition in an election that until recently seemed like a contest between two electoral coalitions that have dominated for years.

    Analysts have drawn parallels between Milei and Trump, because they both espouse socially conservative views and vow to return the country to an unspecified period of greatness.

    Federico Finchelstein, an Argentine historian at New School for Social Research in New York, said Milei is “a Trump who fancies himself an academic.”

    Milei has tapped frustration over Argentina’s triple-digit inflation, which makes many feel like they’re constantly falling behind. Seven out of 10 Argentines say they struggle to make ends meet, noted Roberto Bacman, director of the Center for Public Opinion Studies

    Francisco Beron, 21, a tech worker who listened to Milei from outside the book fair auditorium, said his starting salary last year was the equivalent of $700 a month. Despite two raises since then, Beron now earns less in dollar terms, or about $500.

    “It’s absolute helplessness,” Beron said.

    Finchelstein depicted Milei as the kind of candidate who appears “with magical solutions” when people see traditional politicians as failing to meet their demands.

    Milei sprinkles his economic messages with a heavy dose of conservative policies, such as opposition to abortion, which the country legalized in 2020.

    Milei’s running mate, Victoria Villaruel, the founder of a group that defends former military officers tried for human rights violations during the country’s bloody 1976-1983 dictatorship, has spoken against same-sex marriage, which Argentina legalized in 2010.

    Milei has cut against the grain on many issues. He dismisses current concern over global warming by noting that “10 or 15 years ago there was a discussion that the planet was going to freeze.” He calls sex education a post-Marxist program to destroy ”the most important social core within society, which is the family.” He’s proposed “market mechanisms” to deal with long waiting lists for organ transplants, arguing that organs are a person’s property to sell.

    For many of Milei’s supporters, though, what he proposes takes a back seat to how he proposes it.

    “It’s about vengeance,” Tonelli said. “It’s the vote of ‘these people deserve it because they screwed me over, and now I’m going to screw them over’.”

    Ricardo Poledo, a 51-year-old doctor, said Milei’s appeal is that he calls out politicians as power-hungry kleptocrats. “The last thing they’re concerned about is the people.”

    Poledo listened to Milei at the book fair while wearing the Gadsden flag as a cape. The yellow flag with a rattlesnake and the words “don’t tread on me” is a U.S. symbol often associated with the libertarian right and which Milei and his supporters have adopted.

    Milei’s ascendance is part of a regional change arriving in Argentina later than elsewhere in the hemisphere, Finchelstein said. In Brazil, former President Jair Bolsonaro, often called the tropical Trump, ruled from 2019 to 2022. Elsewhere, right-wing populists are making inroads with a tough-on-crime message.

    In Chile, the right-wing Republican Party recently won the majority of seats in a commission to re-write the country’s constitution. In Paraguay, populist outsider Paraguayo Cubas came in an unexpectedly strong third place in presidential elections last month. And in El Salvador, President Nayib Bukele has seen his popularity soar amid a severe crackdown on gangs that has led to human rights abuses.

    Some analysts have questioned whether Milei can win without a national structure to mobilize votes. For now his popularity has failed to help his allies win elections in provincial races. But Argentina’s presidential election includes a runoff, which means that squeaking by to the second round could be enough for Milei to ultimately win.

    “Milei is a new phenomenon in politics that is difficult to predict,” said Mariel Fornoni of the consultancy Management & Fit. “There is a void, and anything can happen.”

    ___

    Associated Press journalist Almudena Calatrava contributed to this report.

    Source link

  • Trailblazing transgender lawmaker Georgina Beyer dies at 65

    Trailblazing transgender lawmaker Georgina Beyer dies at 65

    WELLINGTON, New Zealand — Georgina Beyer, a trailblazing New Zealand politician who in 1999 became the world’s first openly transgender member of Parliament, died Monday at the age of 65.

    Friends of Beyer said she died peacefully in hospice care. They did not immediately give a cause of death, although Beyer had previously suffered from kidney failure and underwent a kidney transplant in 2017.

    New Zealand Prime Minister Chris Hipkins said he didn’t know Beyer well personally but knew she had a large following within New Zealand and had made a lasting impression on the nation’s parliament.

    “I certainly think that Georgina has blazed a trail that has made it much easier for others to follow,” Hipkins said.

    Friend Malcolm Vaughan said Monday he was still with Beyer, who he had known for decades, and didn’t yet feel ready to talk about her life. He and husband Scott Kennedy instead put out a statement.

    “Georgie was surrounded by her nearest and dearest 24/7 over the past week, she accepted what was happening, was cracking jokes and had a twinkle in her eye, right until the final moment,” they wrote.

    They said she was a national treasure, or “taonga” in Indigenous Māori.

    “Farewell Georgie, your love, compassion and all that you have done for the rainbow and many other communities will live on for ever,” they wrote.

    Beyer, who was Māori, worked as a sex worker and nightclub performer before turning to politics. In 1995 she was elected mayor of the small North Island town of Carterton. Four years later, she won national office for the liberal Labour Party and remained a lawmaker until 2007.

    She helped pass the landmark 2003 Prostitution Reform Act, which decriminalized sex work.

    In a speech to lawmakers at the time, she said the protections the new law offered might have spared her being dragged into the sex industry at the age of 16, and from sex workers being threatened and raped without being able to seek help from police.

    “I think of all the people I have known in that area who have suffered because of the hypocrisy of our society, which, on the one hand, can accept prostitution, while, on the other hand, wants to push it under the carpet and keep it in the twilight world that it exists in,” she told lawmakers.

    In 2004, she helped pass a law allowing same-sex civil unions. Nine years later, New Zealand passed a law allowing same-sex marriage.

    Politicians from both sides of the aisle mourned her death Monday. Nicola Willis, the deputy leader of the conservative National Party, recalled Beyer as brave and gracious.

    “We came from different political sides but she had the power to breach the divide,” Willis wrote on Twitter.

    Source link

  • Today in History: FEB 14, Arizona becomes 48th US state

    Today in History: FEB 14, Arizona becomes 48th US state

    Today in History

    Today is Tuesday, Feb. 14, the 45th day of 2023. There are 320 days left in the year. This is Valentine’s Day.

    Today’s Highlight in History:

    In 1989, Iran’s Ayatollah Khomeini called on Muslims to kill Salman Rushdie, author of “The Satanic Verses,” a novel condemned as blasphemous.

    On this date:

    In 1876, inventors Alexander Graham Bell and Elisha Gray applied separately for patents related to the telephone. (The U.S. Supreme Court eventually ruled Bell the rightful inventor.)

    In 1912, Arizona became the 48th state of the Union as President William Howard Taft signed a proclamation.

    In 1913, labor leader Jimmy Hoffa was born in Brazil, Ind.; college coach Woody Hayes was born in Clifton, Ohio; sports broadcaster Mel Allen was born in Birmingham, Ala.

    In 1924, the Computing-Tabulating-Recording Co. of New York was formally renamed International Business Machines Corp., or IBM.

    In 1929, the “St. Valentine’s Day Massacre” took place in a Chicago garage as seven rivals of Al Capone’s gang were gunned down.

    In 1945, during World War II, British and Canadian forces reached the Rhine River in Germany.

    In 1967, Aretha Franklin recorded her cover of Otis Redding’s “Respect” at Atlantic Records in New York.

    In 1984, 6-year-old Stormie Jones became the world’s first heart-liver transplant recipient when the surgery was performed at Children’s Hospital of Pittsburgh.

    Ten years ago: Double-amputee Olympic sprinter Oscar Pistorius shot and killed his girlfriend, Reeva Steenkamp, at his home in Pretoria, South Africa; he was later convicted of murder and is serving a 13-year prison term.

    Five years ago: A gunman identified as a former student opened fire with a semi-automatic rifle at Marjory Stoneman Douglas High School near Fort Lauderdale, Fla., killing 17 people in the nation’s deadliest school shooting since the attack in Newtown, Conn., more than five years earlier. (Nikolas Cruz pleaded guilty to murder in October 2021 and was sentenced in November 2022 to life in prison without the possibility of parole.)

    One year ago: The Kremlin signaled it was ready to keep talking with the West about security grievances that led to the Ukraine crisis, offering hope that Russia might not invade its neighbor within days. (Russia would invade Ukraine less than a week later.) Canadian Prime Minister Justin Trudeau invoked emergency powers to try to quell the protests by truck drivers and others who paralyzed Ottawa and blocked border crossings in anger over the country’s COVID-19 restrictions.

    Today’s birthdays: Former New York City Mayor Michael Bloomberg is 81. Jazz musician Maceo Parker is 80. Journalist Carl Bernstein is 79. Former Sen. Judd Gregg, R-N.H., is 76. TV personality Pat O’Brien is 75. Magician Teller (Penn and Teller) is 75. Cajun singer-musician Michael Doucet (doo-SAY’) (Beausoleil) is 72. Actor Ken Wahl is 66. Opera singer Renee Fleming is 64. Actor Meg Tilly is 63. Pro Football Hall of Famer Jim Kelly is 63. Singer-producer Dwayne Wiggins is 62. Actor Sakina Jaffrey is 61. Actor Enrico Colantoni is 60. Actor Zach Galligan is 59. Former tennis player Manuela Maleeva is 56. Actor Simon Pegg is 53. Rock musician Kevin Baldes (Lit) is 51. Rock singer Rob Thomas (Matchbox Twenty) is 51. Former NFL quarterback Drew Bledsoe is 51. Actor Danai Gurira is 45. Actor Matt Barr is 39. Actor Stephanie Leonidas is 39. Actor Jake Lacy is 37. Actor Tiffany Thornton is 37. Actor Brett Dier is 33. Actor Freddie Highmore is 31.

    Source link

  • Making pig livers humanlike in quest to ease organ shortage

    Making pig livers humanlike in quest to ease organ shortage

    EDEN PRAIRIE, Minn. — The ghostly form floating in a large jar had been the robust reddish-brown of a healthy organ just hours before. Now it’s semi-translucent, white tubes like branches on a tree showing through.

    This is a pig liver that’s gradually being transformed to look and act like a human one, part of scientists’ long quest to ease the nation’s transplant shortage by bioengineering replacement organs.

    The first step for workers in this suburban Minneapolis lab is to shampoo away the pig cells that made the organ do its work, its color gradually fading as the cells dissolve and are flushed out. What’s left is a rubbery scaffolding, a honeycomb structure of the liver, its blood vessels now empty.

    Next human liver cells — taken from donated organs unable to be transplanted — will be oozed back inside that shell. Those living cells move into the scaffolding’s nooks and crannies to restart the organ’s functions.

    “We essentially regrow the organ,” said Jeff Ross, CEO of Miromatrix. “Our bodies won’t see it as a pig organ anymore.”

    That’s a bold claim. Sometime in 2023, Miromatrix plans first-of-its-kind human testing of a bioengineered organ to start trying to prove it.

    If the Food and Drug Administration agrees, the initial experiment will be outside a patient’s body. Researchers would place a pig-turned-humanlike liver next to a hospital bed to temporarily filter the blood of someone whose own liver suddenly failed. And if that novel “liver assist” works, it would be a critical step toward eventually attempting a bioengineered organ transplant — probably a kidney.

    “It all sounds science fiction-ey but it’s got to start somewhere,” said Dr. Sander Florman, a transplant chief at New York’s Mount Sinai Hospital, one of several hospitals already planning to participate in the liver-assist study. “This is probably more of the near future than xenotransplantation,” or directly implanting animal organs into people.

    More than 105,000 people are on the U.S. waiting list for an organ transplant. Thousands will die before it’s their turn. Thousands more never even get put on the list, considered too much of a long shot.

    “The number of organs we have available are never going to be able to meet the demand,” said Dr. Amit Tevar, a transplant surgeon at the University of Pittsburgh Medical Center. “This is our frustration.”

    That’s why scientists are looking to animals as another source of organs. A Maryland man lived two months after receiving the world’s first heart transplant from a pig last January — an animal genetically modified so its organs didn’t trigger an immediate attack from the human immune system. The FDA is considering whether to allow additional xenotransplantation experiments using kidneys or hearts from gene-edited pigs.

    Bioengineering organs is markedly different — no special pigs required, just leftover organs from slaughterhouses.

    “That is something that in the long term may very likely contribute to the development of organs we can use in humans,” said Pittsburgh’s Tevar. He’s not involved with Miromatrix — and cautioned that the planned outside-the-body testing would be only an early first step.

    The Miromatrix approach stems from research in the early 2000s, when regenerative medicine specialist Doris Taylor and Dr. Harald Ott, then at the University of Minnesota, pioneered a way to completely decellularize the heart of a dead rat. The team seeded the resulting scaffolding with immature heart cells from baby rats that eventually made the little organ beat, garnering international headlines.

    Fast forward, and now at university spinoff Miromatrix sit rows of large jugs pumping fluids and nutrients into livers and kidneys in various stages of their metamorphosis.

    Stripping away the pig cells removes some of the risks of xenotransplantation, such as lurking animal viruses or hyper-rejection, Ross said. The FDA already considers the decellularized pig tissue safe for another purpose, using it to make a type of surgical mesh.

    More complex is getting human cells to take over.

    “We can’t take billions of cells and push them into the organ at once,” Ross said. When slowly infused, “the cells crawl around and when they see the right environment, they stick.”

    The source of those human cells: donated livers and kidneys that won’t be transplanted. Nearly a quarter of kidneys donated in the U.S. last year were discarded because hospitals often refuse to transplant less than perfect organs, or because it took too long to find a matching recipient.

    As long as enough cells still are functioning when donation groups offer up an organ, Miromatrix biologists isolate usable cells and multiply them in lab dishes. From one rescued human organ the company says it can grow enough cells to repopulate several pig liver or kidney scaffolds, cells responsible for different jobs — the kind that line blood vessels or filter waste, for example.

    In 2021, researchers with Miromatrix and the Mayo Clinic reported successfully transplanting a version of bioengineered livers into pigs.

    That set the stage for testing a “liver-assist” treatment similar to dialysis, using bioengineered livers to filter the blood of people in acute liver failure, a life-threatening emergency. Doctors now have little to offer except supportive care unless the person is lucky enough to get a rapid transplant.

    “If you can just get over the hump, then you might actually recover” — because the liver is the only organ that can repair itself and regrow, said Mount Sinai’s Florman. “I’ll be excited when they get their first patient enrolled and I hope that it’s with us.”

    It’s not clear how soon that testing can begin. The FDA recently told Miromatrix it has some questions about the study application.

    If the outside-the-body liver experiment works, what’s next? Still more research aimed at one day attempting to transplant a bioengineered organ — likely a kidney, because a patient could survive with dialysis if the operation failed.

    While regrowing kidneys isn’t as far along, “I was completely stunned” at the progress so far, said Dr. Ron Shapiro, a kidney transplant expert at Mount Sinai.

    He treats many older patients on dialysis who “will wait for years and years to get a kidney and likely die waiting on the list who would be perfect” for such experiments — if they come in time.

    ———

    The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

    Source link